DSC Advisors LP

Search
⚲

DSC Advisors LP ✚
CRD #	158312
SEC #	801-73330
CIK #	0001299434
AUM
Employees	8 (62% Investors, 0% Brokers)
Phone	312-915-2400
Address	900 N Michigan Ave Chicago, IL 60611
Source	[IAPD] [EDGAR] [Website]

Total AUM ($M) Copy

CIK	Period
0001299434	2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31

CIK

Period

0001299434

Sector	Form 13F Holdings	Value ($M)
	Ehealth Inc	2.4
	Kornit Digital Ltd	1.5
	Menlo Therapeutics Inc	1.3
	Facebook Inc	0.6
	Microsoft Corp	0.5
	Alphabet Inc	0.5
	Mastercard Inc	0.4
	Visa Inc	0.4
	Netflix Inc	0.4
	Oracle Corp	0.3
	Salesforce Com Inc	0.3
	Apple Inc	0.3
	Accenture PLC	0.3
	Nvidia Corp	0.3
	Adobe Systems Inc	0.3
	International Business Machines Corp	0.2
	ServiceNow Inc	0.2
	Intuit Inc	0.2













Prev \| Page 1 \| Next

Type	Form D Funds	Date	Sold	AUM
HF	DSC Pe/VC Index Fund LP	[2016-11-03]	5.1 M	5.0 M
	Filed 2021-04-07 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Commission $38,429 · Net Assets Decline to Disclose
HF	DSC Thomson Reuters PE Index Master Fund LP	[2014-03-28]	5.3 M	14.9 M
	Filed 2021-04-07 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	DSC Thomson Reuters VC Index Master Fund LP	[2013-03-25]	10.8 M	17.1 M
	Filed 2026-03-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Delaware Street Capital Master Fund LP	2012-02-10		380.9 M

AUM Breakdown	Accounts	AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	2	380.9
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	0	0.0
Total	2	380.9
By Discretionary
Discretionary	2	380.9
Non-Discretionary	0	0.0
Total	2	380.9
By Non-United States Persons
Non-United States Persons		234.8
United States Persons		146.1
Total	2	380.9

Form D Directors	Role	# Filings	# Firms
Andrew Bluhm	Executive Officer	10	3
David Nietfeldt	Executive Officer	6	3
Arthur Bushonville	Executive Officer	3	2
Dsc QG Partners LLC	Executive Officer	3	2
Steve Bohn	Executive Officer	3	2
Amy Close	Executive Officer	3	2
Dscqg PR LLC	Executive Officer	3	2
Jeffrey Knupp	Executive Officer	1	1

EDGAR Form	CIK	2011 - 2026
13F-HR	[0001299434]
3	[0001299434]
4	[0001299434]
SC 13D	[0001299434]

Form 13D/13G Filer	Form 13D/13G Subject	Filed
DSC Advisors LP	BioScrip Inc	[2014-12-30]

Firm Profile (Form ADV)
Discretionary AUM	$0.2B
Serves	Institutional
Fund Types	Hedge Fund

Form 3/4/5 Subject	2011 - 2026
DSC Advisors LLC
Delaware Street Capital Master Fund LP
Bluhm Andrew G
DSC Managers LLC
DSC Advisors LP
Zevra Therapeutics Inc
Delaware Street Capital L P
Neos Therapeutics Inc

Insider Transaction (Form 3/4/5)	Date	Action	Shares	Price	Value ($)
Zevra Therapeutics Inc KMPH Common Stock, par value $0.0001	2018-10-05	Buy	2,000,000	$3.00	6,000,000
Zevra Therapeutics Inc KMPH Common Stock, par value $0.0001	2018-07-30	Buy	304,283	$4.00	1,217,132
Zevra Therapeutics Inc KMPH Common Stock, par value $0.0001	2017-09-14	Buy	138,857	$3.30	458,228
Zevra Therapeutics Inc KMPH Common Stock, par value $0.0001	2017-09-13	Buy	186,831	$3.25	607,201
Zevra Therapeutics Inc KMPH Common Stock, par value $0.0001	2017-09-13	Buy	200	$3.25	650
Neos Therapeutics Inc NEOS Series C Preferred Stock · derivative	2015-07-28	Conversion	34,153
Neos Therapeutics Inc NEOS Preferred Stock Warrant (Right to Buy) · derivative	2015-07-28	Option exercise	170,766
Neos Therapeutics Inc NEOS Series C Preferred Stock · derivative	2015-07-28	Conversion	1,496,521
Neos Therapeutics Inc NEOS Series B-1 Preferred Stock · derivative	2015-07-28	Conversion	493,982
Neos Therapeutics Inc NEOS Series B Preferred Stock · derivative	2015-07-28	Conversion	153,009
Neos Therapeutics Inc NEOS Common Stock	2015-07-28	Conversion	205,825
Neos Therapeutics Inc NEOS Common Stock	2015-07-28	Conversion	623,550
Neos Therapeutics Inc NEOS Common Stock	2015-07-28	Conversion	14,230
Neos Therapeutics Inc NEOS Common Stock	2015-07-28	Conversion	63,753

DSC Advisors LP

Assets, Funds, Holdings